Paula Schwartz | IR, Rx Communications |
Chris Xu | Chairman and Chief Executive Officer |
Joe Balagot | Senior Vice President of Corporate Development |
Jeff Cauble | Principal Accounting Officer |
Sean Lee | HC Wainwright |
Good day everyone. And welcome to the Cesca Therapeutics Conference Call and Webcast to review Financial and Operating Results for the second quarter ended June 30, 2018.
As a reminder, all participants will be in a listen-only mode. There will be an opportunity for you to ask questions at the end of today's presentation [Operator Instructions] This conference call is being recorded. I would now like to introduce your host for today's conference, Paula Schwartz of Rx Communications.